ASX - By Stock
|
AR9 |
Re:
Ann: AR9 Launches US Federal & Defense Sales & Channel Practice
|
|
LCH
|
29 |
14K |
1 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
29
|
14K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: archTIS acquires Nucleus Cyber
|
|
LCH
|
79 |
25K |
0 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
79
|
25K
|
0
|
|
ASX - By Stock
|
AR9 |
Re:
AR9 $1+
|
|
LCH
|
702 |
286K |
4 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
702
|
286K
|
4
|
|
General
|
|
Re:
Twitter..A danger to free and open communication and expression.
|
|
LCH
|
10 |
1.3K |
0 |
11/11/20 |
11/11/20 |
General
|
10
|
1.3K
|
0
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: archTIS acquires Nucleus Cyber
|
|
LCH
|
79 |
25K |
2 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
79
|
25K
|
2
|
|
ASX - By Stock
|
AR9 |
Re:
AR9 $1+
|
|
LCH
|
702 |
286K |
2 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
702
|
286K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo & Access Bio sign deal for rapid antigen test
|
|
LCH
|
76 |
25K |
0 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
76
|
25K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo & Access Bio sign deal for rapid antigen test
|
|
LCH
|
76 |
25K |
0 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
76
|
25K
|
0
|
|
ASX - By Stock
|
NVX |
Re:
A New Dawn
|
|
LCH
|
104 |
45K |
4 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
104
|
45K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Buckle up for $1
|
|
LCH
|
438 |
149K |
0 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
438
|
149K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Buckle up for $1
|
|
LCH
|
438 |
149K |
1 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
438
|
149K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Buckle up for $1
|
|
LCH
|
438 |
149K |
2 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
438
|
149K
|
2
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: archTIS secures data access control Proof of Concept
|
|
LCH
|
18 |
9.5K |
8 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
18
|
9.5K
|
8
|
|
ASX - By Stock
|
RGL |
Re:
Ann: Change in substantial holding
|
|
LCH
|
13 |
4.4K |
4 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
13
|
4.4K
|
4
|
|
ASX - By Stock
|
RGL |
Re:
Ann: Change in substantial holding
|
|
LCH
|
13 |
4.4K |
0 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
13
|
4.4K
|
0
|
|
ASX - By Stock
|
RGL |
Re:
Ann: Change in substantial holding
|
|
LCH
|
13 |
4.4K |
1 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
13
|
4.4K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: archTIS wins Information Security services contract
|
|
LCH
|
64 |
24K |
4 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
64
|
24K
|
4
|
|
ASX - By Stock
|
AR9 |
Re:
AR9 $1+
|
|
LCH
|
702 |
286K |
3 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
702
|
286K
|
3
|
|
ASX - By Stock
|
NVX |
Re:
CATL to invest US 2.5B overseas
|
|
LCH
|
10 |
3.9K |
1 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
10
|
3.9K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Appendix 4C - quarterly
|
|
LCH
|
392 |
135K |
3 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
392
|
135K
|
3
|
|
ASX - By Stock
|
NOV |
Re:
NOV Chart
|
|
LCH
|
824 |
228K |
3 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
824
|
228K
|
3
|
|
Charts
|
AR9 |
Re:
AR9 chart
|
|
LCH
|
479 |
181K |
2 |
11/08/20 |
11/08/20 |
Charts
|
479
|
181K
|
2
|
|
ASX - By Stock
|
NVX |
Re:
NVX Chart
|
|
LCH
|
322 |
136K |
0 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
322
|
136K
|
0
|
|
ASX - By Stock
|
NVX |
Re:
NVX Chart
|
|
LCH
|
322 |
136K |
3 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
322
|
136K
|
3
|
|
ASX - By Stock
|
AR9 |
Re:
Cracking Fifty Cents
|
|
LCH
|
19 |
7.1K |
1 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
19
|
7.1K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Cracking Fifty Cents
|
|
LCH
|
19 |
7.1K |
0 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
19
|
7.1K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo receives TGA approval for COVID19 antibody test
|
|
LCH
|
136 |
47K |
7 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
136
|
47K
|
7
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo receives TGA approval for COVID19 antibody test
|
|
LCH
|
136 |
47K |
6 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
136
|
47K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
Strong close today
|
|
LCH
|
48 |
20K |
2 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
48
|
20K
|
2
|
|
ASX - By Stock
|
NOV |
Re:
Ann: June 2020 Quarterly Update
|
|
LCH
|
42 |
11K |
1 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
42
|
11K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Appendix 4C - quarterly
|
|
LCH
|
392 |
135K |
1 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
392
|
135K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Appendix 4C - quarterly
|
|
LCH
|
392 |
135K |
3 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
392
|
135K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Investor Presentation 29 July 2020
|
|
LCH
|
13 |
5.9K |
6 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
13
|
5.9K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
Potential SP Valuation of AT1 - 80 cents to 1.30/share
|
|
LCH
|
1.3K |
593K |
4 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
1.3K
|
593K
|
4
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Appendix 4C - quarterly
|
|
LCH
|
392 |
135K |
1 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
392
|
135K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo & Access Bio enter North American COVID-19 partnership
|
|
LCH
|
175 |
68K |
8 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
175
|
68K
|
8
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Appendix 4C - quarterly
|
|
LCH
|
392 |
135K |
1 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
392
|
135K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Appendix 4C - quarterly
|
|
LCH
|
392 |
135K |
2 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
392
|
135K
|
2
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Appendix 4C - quarterly
|
|
LCH
|
392 |
135K |
0 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
392
|
135K
|
0
|
|
ASX - By Stock
|
NOV |
Re:
Ann: June 2020 Quarter Processing Revenue Update
|
|
LCH
|
16 |
4.6K |
2 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
16
|
4.6K
|
2
|
|
Charts
|
AR9 |
Re:
AR9 chart
|
|
LCH
|
479 |
181K |
0 |
24/07/20 |
24/07/20 |
Charts
|
479
|
181K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Quarterly Activity Report & Appendix 4C - 30 June 2020
|
|
LCH
|
58 |
20K |
2 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
58
|
20K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Quarterly Activity Report & Appendix 4C - 30 June 2020
|
|
LCH
|
58 |
20K |
7 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
58
|
20K
|
7
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Quarterly Activity Report & Appendix 4C - 30 June 2020
|
|
LCH
|
58 |
20K |
8 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
58
|
20K
|
8
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: archTIS Renews Contracts with Commonwealth Government
|
|
LCH
|
124 |
31K |
1 |
20/07/20 |
20/07/20 |
ASX - By Stock
|
124
|
31K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: archTIS Renews Contracts with Commonwealth Government
|
|
LCH
|
124 |
31K |
2 |
18/07/20 |
18/07/20 |
ASX - By Stock
|
124
|
31K
|
2
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: archTIS Renews Contracts with Commonwealth Government
|
|
LCH
|
124 |
31K |
1 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
124
|
31K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
40c party
|
|
LCH
|
41 |
12K |
3 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
41
|
12K
|
3
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Corporate Presentation
|
|
LCH
|
147 |
35K |
1 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
147
|
35K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Potential SP Valuation of AT1 - 80 cents to 1.30/share
|
|
LCH
|
1.3K |
593K |
9 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
1.3K
|
593K
|
9
|
|